In conversation with... Rupert Leong
from Listen to The Lancet Gastroenterology & Hepatology Hosted by The Lancet
Rupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?
This episode is 13 minutes long.
When was this Listen to The Lancet Gastroenterology & Hepatology episode published?
This episode was published on March 12, 2022.
Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.